Rise in the incidence of respiratory disorders and advancement in the technology, such as production of lightweight and easy to use devices drive the market growth. In addition, rise in purchasing power in the developing regions such as, Asia-Pacific and LAMEA are projected to lead to growth in the smart pulse oximeters market.

Portland, OR -- (SBWire) -- 05/31/2018 --For people with COPD, asthma, Congestive Heart Failure (CHF) and other conditions, pulse oximetry is a technology used to measure the oxygen level in your blood and your heart rate. A finger pulse oximeter is equipped with technology to rapidly detect changes in your blood oxygen level.

A finger pulse oximeter functions by shining light through your finger. The sensors detect how much oxygen is in your blood based on the way the light passes through your finger. Pulse oximetry is the technology calculating the results to display a number on the oximeter's screen that tells you the percent of oxygen in your blood. A finger pulse oximeter also measures your pulse rate.

The demand for pulse oximeters is expected to increase in the near future, owing to efficient diagnosis of critical health conditions and ability to track the health status of patients in home settings. Rise in geriatric population and chronic health conditions such as, COPD and obesity, increase in preference for home monitoring, and growth in awareness among patients about smart pulse oximeters are expected to drive the market growth. However, lack of awareness and adoption of these devices in low- and middle-income economies are projected to hamper the market growth.

Get the PDF sample of Pulse Oximeters Market Study at: https://www.alliedmarketresearch.com/request-sample/1944

Fingertip pulse oximeters market anticipated to dominate the global smart pulse oximeters market in 2015 and expected to maintain its dominance throughout the analysis period. This is owing to the ease of use and lightweight features, wide adoption at home settings and increase in the global incidence of respiratory disorders, such as COPD.

The global smart pulse oximeters by product type is further segmented by end users into hospitals & clinics, ambulatory surgery centers (ASCs), and home care settings. The hospitals & clinics segment was the highest revenue contributor to the fingertip pulse oximeters market in 2015, and is expected to maintain its dominance during the analysis period. Smart pulse oximeters facilitate early detection of a disease and thereby allows faster intervention and diagnosis.

North America dominated the global smart pulse oximeters market in 2015, and is expected to maintain its dominance during the forecast period. This is attributed to the rise in respiratory disorders, growth in awareness among patients regarding cost-effective pulse oximeters, high purchasing power, and availability of advanced healthcare facilities in the North American countries.

Key findings of the Smart Pulse Oximeters Market

Based on product type, the fingertip pulse oximeters segment was the highest revenue contibutor, growing at a CAGR of 7.5% during the analysis period.

The ASCs segment for fingertip pulse oximeters market is estimated to grow at the highest CAGR of 8.6% from 2016 to 2022, as fingertip pulse oximeters can be used easily by patients and do not require trained professional for operating the device.

Developing regions are projected to be the fastest growing region until 2022, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of COPD, sleep apnea, and other respiratory disorders in this region, and increase in disposable income of the population.

Russia is projected to be the fastest growing country in the European region, growing at a CAGR of 9.2% during the analysis period.

Do purchase inquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1944

Key players in the global pulse oximeters market include Contec Medical Systems Co., Ltd., General Electric Company, Halma plc, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Nonin Medical, Inc., Omron Corporation, and Smiths Group plc.